Counter-Ion Content: Trifluoroacetate and Acetate

A synthetic peptide is almost never isolated as a free base. It is isolated as a salt, and the counter-ion is a substantial fraction of the mass that a balance reports. For a basic sequence purified by the standard route the trifluoroacetate contribution can approach a quarter of the weighed solid. That mass is invisible to a purity assay, invisible to a mass spectrum of the peptide, and fully present on the balance. Together with residual water and residual salt, it is the reason gross weight and peptide mass are different numbers.

Why synthesised peptides arrive as salts

Solid-phase synthesis, in the form established by Merrifield, assembles the chain on an insoluble support and releases it at the end by acidolysis 1. The cleavage cocktail is strongly acidic; trifluoroacetic acid is its dominant component and simultaneously removes most side-chain protecting groups. The crude product therefore enters purification already protonated at every basic site and already paired with trifluoroacetate.

Purification entrenches it. Reversed-phase chromatography of peptides uses trifluoroacetic acid as the mobile-phase modifier because it suppresses interaction with residual silanols, ion-pairs with the basic residues to improve retention, and sharpens peaks that would otherwise tail badly. It is also strongly acidic and fully ionised at working pH, so it stays paired through the separation. Fractions are then lyophilised directly from the acidified water and acetonitrile they eluted in. Water and acetonitrile leave; the acid does not. The dry solid recovered at the end is a trifluoroacetate salt by construction, and no step in the ordinary workflow removes it.

Load is set by chemistry rather than by chance. Each protonatable basic site can carry one equivalent: the arginine, lysine and histidine side chains, and the free N-terminal amine where the terminus is not capped. Acidic side chains and a free C-terminal carboxylate work in the other direction, reducing the net positive charge that requires balancing. Measured loads commonly fall somewhat below the theoretical maximum, in the region of seven to ten equivalents per ten basic sites, because drying conditions and the final wash both remove some of it.

How much mass it represents

The arithmetic is straightforward and worth doing once, because the intuition it produces is more useful than any single number. Take a generic free base of 1,500 g·mol⁻¹ and add counter-ions of different identity at one equivalent per basic site.

Two conclusions follow. The first is that counter-ion is the largest of the non-peptide terms for a basic sequence, typically exceeding residual water by a factor of three or more. The second is that identity matters as much as count: acetate contributes roughly 59 mass units per equivalent against 113 for trifluoroacetate, so exchanging one for the other recovers most of the difference and shifts net peptide content upward by several percentage points without changing the peptide at all.

The comparison problem this creates is the practical one. Two sequences of identical molecular weight, one carrying five basic residues and one carrying one, differ by around twenty percentage points of net peptide content as trifluoroacetate salts. Both containers may state the same solid mass. Neither statement is wrong, and the quantities of peptide inside them are materially different.

Exchange, and when to request it

Counter-ion exchange replaces trifluoroacetate with acetate, chloride or another anion. Several routes exist and they are not equivalent in completeness.

1. Repeated lyophilisation from dilute hydrochloric acid, which displaces trifluoroacetate and leaves the hydrochloride. Acid concentration is the variable that matters: too dilute and displacement is incomplete, too concentrated and the peptide is damaged.
2. Repeated lyophilisation from dilute acetic acid or from ammonium acetate, giving the acetate salt. Ammonium acetate is volatile enough to sublime during drying, which is why it is favoured.
3. Anion-exchange chromatography on a resin pre-loaded in the desired counter-ion form, which is the most complete route and the most material-intensive.
4. Solid-phase extraction with a wash in the desired acid before elution, effective as a finishing step rather than a primary exchange.
5. Repurification using an alternative mobile-phase modifier, such as formic acid or an acetate buffer, which avoids introducing trifluoroacetate in the first place at some cost in peak shape.

Systematic comparison of these approaches found that several leave residual trifluoroacetate at levels well above what an operator would assume, and that repetition matters more than the choice of route: a single treatment is rarely sufficient, while three cycles of the same treatment usually are 3. The hydrochloric acid route in particular has an optimum concentration window, and working outside it fails in one direction or the other 2. Where the exchange has been performed by a supplier, the useful question is not which method was used but how many cycles and what the residual level was measured to be afterwards.

Exchange is worth requesting when the downstream measurement is sensitive to the anion, and not otherwise. Cell-based work is the principal case. Far-ultraviolet spectroscopy is the second: trifluoroacetate absorbs strongly below 230 nm, which degrades circular dichroism spectra in the region where secondary structure is read, and rules out concentration determination by peptide-bond absorbance. Ion-sensitive assays, calorimetry and any work where the acetate itself would buffer the system make up the rest. For a preparation destined only for chromatographic or mass-spectrometric characterisation, exchange adds cost, adds handling losses and changes nothing that matters.

Cell-culture toxicity

The specific reason exchange became standard practice for cell work is that trifluoroacetate is not inert. It was identified as an active contaminant in purified protein preparations, inhibiting the proliferation of osteoblasts and chondrocytes at concentrations reachable from residual counter-ion in an ordinary dilution rather than from any deliberate addition 4. The effect is on the anion itself, so it is independent of the peptide it accompanied.

Later work generalised the finding. Comparing matched preparations of the same sequences as trifluoroacetate, acetate and hydrochloride salts showed the counter-ion altering measured cytotoxicity and, in some systems, measured activity — meaning that two laboratories testing the same peptide can obtain different numbers because they bought different salts 5. That is a reproducibility problem rather than a safety one, and it is invisible unless the salt form is recorded.

The practical inference is narrow. Where a cell-based readout is the endpoint, record the counter-ion form and its measured level, include a vehicle control that carries the same anion at the same concentration, and treat a result generated on trifluoroacetate salt as not directly comparable to one generated on acetate salt. Where the endpoint is physical or chemical, the anion is a mass-accounting term and nothing more.

Reading the figure, and closing the mass accounting

Counter-ion content appears on a certificate less often than it should, and when it appears it takes several forms. A bare statement of salt form — trifluoroacetate salt, acetate salt — is a form declaration and carries no quantity. A percentage by mass is the useful figure, provided the denominator is the whole solid rather than the peptide. A figure in equivalents per mole is equally useful and requires the free-base molecular weight to convert. A residual level quoted after an exchange, expressed in parts per million, answers a different question again: it says how much of the old anion remains, not how much of the new one is present.

1. Read the salt form first, and check whether it matches what the downstream assay requires.
2. Look for a quantity, and establish its denominator before comparing it with anything.
3. Check the determination method. Ion chromatography and fluorine nuclear magnetic resonance are specific; titration is not.
4. Check the date against any exchange step. A pre-exchange figure does not describe post-exchange material.
5. Reconcile the four terms if the data allow: peptide, counter-ion, water and non-peptide salt should sum to the weighed mass.
6. Use the free-base molecular weight in every molar calculation, after applying net peptide content. Using the salt molecular weight counts the counter-ion twice.
7. Record the salt form alongside every derived concentration, so that a later comparison against a differently salted lot is recognisable as one.

This is the last of the four terms. Peptide purity describes what fraction of the peptide-related material is the intended sequence. Net peptide content describes what fraction of the weighed solid is peptide at all. Residual moisture accounts for the water, measurable by titration on a few milligrams. Counter-ion content accounts for the anion, measurable by ion chromatography. Only when all four are on the table does a stated mass become a stated quantity of molecules — and in ordinary practice at least two of them are missing, which is the honest reason a concentration derived from a label should carry the word nominal.